Cormorant Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,081,490
Closed -$3.08M 67
2023
Q1
$3.08M Buy
+1,081,490
New +$3.08M 0.2% 55